About Weimei Biotech
Redefining Skin Health Through Science and Innovation
Founded in 2012 and headquartered in Zhuhai, Guangdong, Weimei Biotech Co., Ltd. is a leading high-tech enterprise specializing in medical aesthetics and dermatological health. The parent company is Rixin Cosmetics, which has been engaged in Skincare Industry Manufacturing since 1998With over a decade of dedicated research in skin repair science, we focus on plant-based actives—particularly Ganoderma (Reishi mushroom)—to develop innovative solutions for daily skincare and post-procedural wound care.
Scientific Excellence in Skin Regeneration
At Weimei Biotech, our mission is simple yet profound: to restore skin health through biotechnology. Guided by the principles of science, exploration, and precision, we are committed to the research, development, and production of biologically active ingredients for advanced skin repair. We aim to lead and shape the future of medical-grade skin restoration products.
Our flagship brand, Kefujia, is built on patented active ingredients like Ganoderma Polysaccharides (a synergistic combination of Chitosan and β-Glucan). This innovation offers powerful effects including antibacterial action, hemostasis, pain relief, fluid absorption, wound healing, and scar prevention—applied across functional skincare and Class II medical dressings.
Advanced Manufacturing & Certifications
Weimei Biotech operates its own GMP-certified production facilities equipped with world-class technology and automation. Our certifications include:
ISO 13485:2016
Our ISO 13485 certification ensures our medical device manufacturing meets strict international quality standards, guaranteeing consistent product safety, reliability, and compliance throughout the design, production, and distribution processes.
These ensure strict quality control and regulatory compliance for both cosmetic and medical product lines.
Innovation Backed by Patents & Research
In partnership with the Chinese Academy of Sciences, Weimei Biotech has developed multiple patented ingredients, including Ganoderma Chitosan (Patent No. 202210250399.3). Our medical polysaccharide series has received Class II Medical Device Registration in China.
Our solutions have been widely adopted for wound types in our domestic hospital including:
Trusted by the Industry
Weimei Biotech is a recognized industry leader and was appointed as a board member of the Guangdong Cosmetic Association. We’ve been featured at national academic forums, such as the Chinese Association of Integrative Dermatology, where our brand Kefujia received accolades for scientific innovation and clinical efficacy.
In 2023, Kefujia was awarded “Annual Technology Innovation Brand” at the China Aesthetic Medicine Leaders Summit, marking a milestone in biotechnological skincare advancement.
Our Commitment
As a pioneer in biotech-based wound healing, Weimei Biotech is committed to:
- Driving forward the clinical transformation of active ingredient research
- Offering scientific, effective solutions for diverse skin repair needs
- Supporting healthcare professionals and B2B partners with cutting-edge technology and reliable manufacturing
We continue to empower skin health with nature-derived biotechnology—bridging traditional wisdom and modern science, delivering visible results in beauty and healing.